Complete breakdown of GC101 TIL therapy costs — transparent pricing with no hidden fees. Treatment in China costs approximately one-fifth of equivalent therapy in the US.
The total estimated cost for GC101 TIL therapy in China is approximately $110,000, which includes the complete treatment pathway — from tumor collection through cell manufacturing, infusion, and follow-up monitoring. By comparison, the US-approved TIL therapy (Iovance's lifileucel / Amtagvi) costs approximately $515,000 before additional hospital and supportive care expenses (lymphodepletion, IL-2, ICU stay).
Important: GC101 is an investigational therapy currently in clinical trials. Trial participation provides free treatment under close medical supervision. The costs below apply to patients receiving GC101 through clinical trial enrollment pathways.
| Item | Estimated Cost (USD) |
|---|---|
| Tumor tissue collection procedure (minimally invasive) | $5,000 – $8,000 |
| Cell manufacturing (GC101 DeepTIL platform) | $55,000 – $70,000 |
| Cell infusion and hospitalization (3 days, Hainan) | $15,000 – $20,000 |
| Pre-treatment evaluation and testing | $3,000 – $5,000 |
| Post-treatment follow-up monitoring (6 months) | $5,000 – $8,000 |
| Case management and coordination | Included |
| Estimated Total | ~$110,000 |
| Factor | GC101 (China) | Lifileucel (US) |
|---|---|---|
| Base treatment cost | ~$110,000 | $515,000 |
| Lymphodepletion chemo | Not required (included) | $20,000 – $50,000 |
| IL-2 administration | Not required (included) | $10,000 – $30,000 |
| ICU stay | Typically not needed | $50,000 – $100,000 |
| Travel & accommodation | $8,000 – $15,000 | Local (included) |
| Estimated total | ~$120,000 – $130,000 | $600,000 – $700,000+ |
Contact us for a detailed cost breakdown based on your specific cancer type and treatment needs.
Email clinicaltrials@juncell.comYes. CancerPath offers a free initial eligibility assessment where we review your medical records and determine whether GC101 TIL therapy may be appropriate for you. There is no cost and no obligation.
Payment terms are arranged directly with the hospital and treatment provider. We can discuss available options during your consultation. Typically, payment is structured in stages: a deposit upon eligibility confirmation, a manufacturing fee, and the balance before infusion.
International health insurance typically does not cover treatment in China. Some patients have successfully obtained reimbursement from their insurance companies on a case-by-case basis. We can provide the necessary documentation to support insurance claims.
Treatment eligibility is confirmed during the free consultation before any financial commitment. Full payment is only required once eligibility is confirmed.